BIOM raises €2 million led by Swanlaab to fight Xylella

According to the European Food Safety Authority (EFSA), the bacterium has infected and killed 21 million trees in the olive groves of Puglia. In Alicante, data published in May 2026 show more than 315,000 almond trees have been removed under the eradication programme since 2017. EFSA also estimates that its spread across the EU could cause production losses of €5.5 billion a year.

Qsystem® is a biological technology still in development and validation, which has shown promising preliminary results in field trials on infected olive and almond trees. The funding will allow BIOM to extend those validations and prepare the studies and documentation needed for future registration.

Probio® and Growth®

The platform also includes Probio®, a dual liquid medium meant to make sure microorganisms in agricultural microbial products reach the crop alive and active. It keeps them stable in storage and, once diluted in water, becomes a nutrient source that helps reactivate and grow them. Growth® is a line of culture media optimised for industrial production of microorganisms and their metabolites.

The round will also fund validation and industrial scale-up of BIOM's production processes and the market launch of its products. CEO Inés Arteaga said bringing such technologies to market requires proving efficacy, scaling production and meeting regulatory requirements, a long path that firms like BIOM cannot walk alone before earning revenue.

Roger Salameh, Partner at Swanlaab, said the fund was drawn by the breadth of the platform, the relevance of the problems it tackles and confidence in the management team.